ID   SIR7_HUMAN              Reviewed;         400 AA.
AC   Q9NRC8; A8K2K0; B3KSU8; Q3MIK4; Q9NSZ6; Q9NUS6;
DT   31-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   12-APR-2017, entry version 145.
DE   RecName: Full=NAD-dependent protein deacetylase sirtuin-7;
DE            EC=3.5.1.-;
DE   AltName: Full=Regulatory protein SIR2 homolog 7;
DE   AltName: Full=SIR2-like protein 7;
GN   Name=SIRT7; Synonyms=SIR2L7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=10873683; DOI=10.1006/bbrc.2000.3000;
RA   Frye R.A.;
RT   "Phylogenetic classification of prokaryotic and eukaryotic Sir-2 like
RT   proteins.";
RL   Biochem. Biophys. Res. Commun. 273:793-798(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Cerebellum, Colon, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 128-400 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11953824; DOI=10.1038/sj.bjc.6600156;
RA   de Nigris F., Cerutti J., Morelli C., Califano D., Chiariotti L.,
RA   Viglietto G., Santelli G., Fusco A.;
RT   "Isolation of a SIR-like gene, SIR-T8, that is overexpressed in
RT   thyroid carcinoma cell lines and tissues.";
RL   Br. J. Cancer 86:917-923(2002).
RN   [7]
RP   ERRATUM.
RX   PubMed=12454780; DOI=10.1038/sj.bjc.6600636;
RA   De Nigris F., Cerutti J., Morelli C., Califano D., Chiariotti L.,
RA   Viglietto G., Santelli G., Fusco A.;
RL   Br. J. Cancer 87:1479-1479(2002).
RN   [8]
RP   SHOWS THAT SIR-T8 IS SIRT7.
RX   PubMed=12454781; DOI=10.1038/sj.bjc.6600635;
RA   Frye R.A.;
RT   "'SIRT8' expressed in thyroid cancer is actually SIRT7.";
RL   Br. J. Cancer 87:1479-1479(2002).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16079181; DOI=10.1091/mbc.E05-01-0033;
RA   Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I.;
RT   "Evolutionarily conserved and nonconserved cellular localizations and
RT   functions of human SIRT proteins.";
RL   Mol. Biol. Cell 16:4623-4635(2005).
RN   [10]
RP   FUNCTION, IDENTIFICATION IN A RNA POLYMERASE I COMPLEX, INTERACTION
RP   WITH HISTONE H2A AND/OR HISTONE H2B, MUTAGENESIS OF SER-111 AND
RP   HIS-187, AND SUBCELLULAR LOCATION.
RX   PubMed=16618798; DOI=10.1101/gad.1399706;
RA   Ford E., Voit R., Liszt G., Magin C., Grummt I., Guarente L.;
RT   "Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I
RT   transcription.";
RL   Genes Dev. 20:1075-1080(2006).
RN   [11]
RP   FUNCTION, INTERACTION WITH UBTF, PHOSPHORYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=19174463; DOI=10.1242/jcs.042382;
RA   Grob A., Roussel P., Wright J.E., McStay B., Hernandez-Verdun D.,
RA   Sirri V.;
RT   "Involvement of SIRT7 in resumption of rDNA transcription at the exit
RT   from mitosis.";
RL   J. Cell Sci. 122:489-498(2009).
RN   [12]
RP   SUBCELLULAR LOCATION, INTERACTION WITH MYBBP1A; SMARCA5 AND BAZ1B, AND
RP   MUTAGENESIS OF SER-111.
RX   PubMed=22586326; DOI=10.1074/mcp.A111.015156;
RA   Tsai Y.C., Greco T.M., Boonmee A., Miteva Y., Cristea I.M.;
RT   "Functional proteomics establishes the interaction of SIRT7 with
RT   chromatin remodeling complexes and expands its role in regulation of
RT   RNA polymerase I transcription.";
RL   Mol. Cell. Proteomics 11:M111.015156.01-M111.015156.17(2012).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   ELK4, AND MUTAGENESIS OF HIS-187.
RX   PubMed=22722849; DOI=10.1038/nature11043;
RA   Barber M.F., Michishita-Kioi E., Xi Y., Tasselli L., Kioi M.,
RA   Moqtaderi Z., Tennen R.I., Paredes S., Young N.L., Chen K., Struhl K.,
RA   Garcia B.A., Gozani O., Li W., Chua K.F.;
RT   "SIRT7 links H3K18 deacetylation to maintenance of oncogenic
RT   transformation.";
RL   Nature 487:114-118(2012).
RN   [14]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-388, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: NAD-dependent protein deacetylase that specifically
CC       mediates deacetylation of histone H3 at 'Lys-18' (H3K18Ac). In
CC       contrast to other histone deacetylases, displays selectivity for a
CC       single histone mark, H3K18Ac, directly linked to control of gene
CC       expression. H3K18Ac is mainly present around the transcription
CC       start site of genes and has been linked to activation of nuclear
CC       hormone receptors. SIRT7 thereby acts as a transcription
CC       repressor. Moreover, H3K18 hypoacetylation has been reported as a
CC       marker of malignancy in various cancers and seems to maintain the
CC       transformed phenotype of cancer cells. These data suggest that
CC       SIRT7 may play a key role in oncogenic transformation by
CC       suppresses expression of tumor suppressor genes by locus-specific
CC       deacetylation of H3K18Ac at promoter regions. Also required to
CC       restore the transcription of ribosomal RNA (rRNA) at the exit from
CC       mitosis: promotes the association of RNA polymerase I with the
CC       rDNA promoter region and coding region. Stimulates transcription
CC       activity of the RNA polymerase I complex. May also deacetylate
CC       p53/TP53 and promotes cell survival, however such data need
CC       additional confirmation. {ECO:0000269|PubMed:16618798,
CC       ECO:0000269|PubMed:19174463, ECO:0000269|PubMed:22722849}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + an acetylprotein = nicotinamide + O-
CC       acetyl-ADP-ribose + a protein. {ECO:0000255|PROSITE-
CC       ProRule:PRU00236, ECO:0000269|PubMed:22722849}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with UBTF and the RNA polymerase I complex.
CC       Interacts with components of the B-WICH complex, such as MYBBP1A,
CC       SMARCA5/SNF2H and BAZ1B/WSTF. Interacts with ELK4, leading to
CC       stabilization at target promoters for H3K18Ac deacetylation.
CC       Interacts with histone H2A and/or histone H2B.
CC       {ECO:0000269|PubMed:16618798, ECO:0000269|PubMed:19174463,
CC       ECO:0000269|PubMed:22586326, ECO:0000269|PubMed:22722849}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus, nucleolus. Note=Located
CC       close to the nuclear membrane when in the cytoplasm. Associated
CC       with chromatin. Associated with rDNA promoter and transcribed
CC       region. Associated with nucleolar organizer regions during
CC       mitosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NRC8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRC8-2; Sequence=VSP_008736, VSP_008737;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9NRC8-3; Sequence=VSP_044396, VSP_044397;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated during mitosis. {ECO:0000305|PubMed:19174463}.
CC   -!- MISCELLANEOUS: Overexpressed in human thyroid carcinoma cell lines
CC       and tissues, but not in adenomas.
CC   -!- SIMILARITY: Belongs to the sirtuin family. Class IV subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally (PubMed:11953824) termed SIR-T8/SIRT8.
CC       This was later retracted (PubMed:12454780). See also
CC       PubMed:12454781. {ECO:0000305|PubMed:11953824}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB70848.2; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF233395; AAF43431.1; -; mRNA.
DR   EMBL; AK002027; BAA92044.1; -; mRNA.
DR   EMBL; AK094326; BAG52860.1; -; mRNA.
DR   EMBL; AK290265; BAF82954.1; -; mRNA.
DR   EMBL; AC145207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017305; AAH17305.1; -; mRNA.
DR   EMBL; BC101791; AAI01792.1; -; mRNA.
DR   EMBL; BC101793; AAI01794.1; -; mRNA.
DR   EMBL; AL137626; CAB70848.2; ALT_SEQ; mRNA.
DR   CCDS; CCDS11792.1; -. [Q9NRC8-1]
DR   PIR; T46324; T46324.
DR   RefSeq; NP_057622.1; NM_016538.2. [Q9NRC8-1]
DR   UniGene; Hs.514636; -.
DR   ProteinModelPortal; Q9NRC8; -.
DR   SMR; Q9NRC8; -.
DR   BioGrid; 119602; 664.
DR   DIP; DIP-59906N; -.
DR   IntAct; Q9NRC8; 7.
DR   MINT; MINT-1424083; -.
DR   STRING; 9606.ENSP00000329466; -.
DR   ChEMBL; CHEMBL2163184; -.
DR   iPTMnet; Q9NRC8; -.
DR   PhosphoSitePlus; Q9NRC8; -.
DR   BioMuta; SIRT7; -.
DR   DMDM; 38258650; -.
DR   EPD; Q9NRC8; -.
DR   MaxQB; Q9NRC8; -.
DR   PaxDb; Q9NRC8; -.
DR   PeptideAtlas; Q9NRC8; -.
DR   PRIDE; Q9NRC8; -.
DR   DNASU; 51547; -.
DR   Ensembl; ENST00000328666; ENSP00000329466; ENSG00000187531. [Q9NRC8-1]
DR   GeneID; 51547; -.
DR   KEGG; hsa:51547; -.
DR   UCSC; uc002kcj.3; human. [Q9NRC8-1]
DR   CTD; 51547; -.
DR   DisGeNET; 51547; -.
DR   GeneCards; SIRT7; -.
DR   HGNC; HGNC:14935; SIRT7.
DR   HPA; CAB037261; -.
DR   HPA; HPA053669; -.
DR   MIM; 606212; gene.
DR   neXtProt; NX_Q9NRC8; -.
DR   OpenTargets; ENSG00000187531; -.
DR   PharmGKB; PA37940; -.
DR   eggNOG; KOG1905; Eukaryota.
DR   eggNOG; COG0846; LUCA.
DR   GeneTree; ENSGT00530000063706; -.
DR   HOGENOM; HOG000231240; -.
DR   HOVERGEN; HBG060028; -.
DR   InParanoid; Q9NRC8; -.
DR   KO; K11417; -.
DR   OMA; EVCTACT; -.
DR   OrthoDB; EOG091G00MI; -.
DR   PhylomeDB; Q9NRC8; -.
DR   TreeFam; TF106184; -.
DR   SIGNOR; Q9NRC8; -.
DR   ChiTaRS; SIRT7; human.
DR   GeneWiki; SIRT7; -.
DR   GenomeRNAi; 51547; -.
DR   PRO; PR:Q9NRC8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000187531; -.
DR   CleanEx; HS_SIRT7; -.
DR   ExpressionAtlas; Q9NRC8; baseline and differential.
DR   Genevisible; Q9NRC8; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005731; C:nucleolus organizer region; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070403; F:NAD+ binding; IEA:InterPro.
DR   GO; GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IDA:UniProtKB.
DR   GO; GO:0070932; P:histone H3 deacetylation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0007072; P:positive regulation of transcription involved in exit from mitosis; IMP:UniProtKB.
DR   GO; GO:0009303; P:rRNA transcription; IMP:UniProtKB.
DR   Gene3D; 3.40.50.1220; -; 1.
DR   InterPro; IPR029035; DHS-like_NAD/FAD-binding_dom.
DR   InterPro; IPR003000; Sirtuin.
DR   InterPro; IPR026590; Ssirtuin_cat_dom.
DR   Pfam; PF02146; SIR2; 1.
DR   SUPFAM; SSF52467; SSF52467; 1.
DR   PROSITE; PS50305; SIRTUIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromatin regulator; Complete proteome;
KW   Cytoplasm; Hydrolase; Metal-binding; Methylation; NAD; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    400       NAD-dependent protein deacetylase
FT                                sirtuin-7.
FT                                /FTId=PRO_0000110271.
FT   DOMAIN       90    331       Deacetylase sirtuin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00236}.
FT   NP_BIND     107    126       NAD. {ECO:0000250}.
FT   NP_BIND     167    170       NAD. {ECO:0000250}.
FT   NP_BIND     268    270       NAD. {ECO:0000250}.
FT   NP_BIND     297    299       NAD. {ECO:0000250}.
FT   COMPBIAS      8     74       Arg-rich.
FT   ACT_SITE    187    187       Proton acceptor.
FT   METAL       195    195       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236}.
FT   METAL       198    198       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236}.
FT   METAL       225    225       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236}.
FT   METAL       228    228       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00236}.
FT   BINDING     315    315       NAD; via amide nitrogen. {ECO:0000250}.
FT   MOD_RES     388    388       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   VAR_SEQ       1     30       MAAGGLSRSERKAAERVRRLREEQQRERLR -> MPGPRRR
FT                                SPSACP (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044396.
FT   VAR_SEQ     162    183       QHVVSQNCDGLHLRSGLPRTAI -> RALGGWYTCQGPGRA
FT                                PWCPVGN (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008736.
FT   VAR_SEQ     184    400       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_008737.
FT   VAR_SEQ     336    400       WQDPIFSLATPLRAGEEGSHSRKSLCRSREEAPPGDRGAPL
FT                                SSAPILGGWFGRGCTKRTKRKKVT -> VL (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044397.
FT   MUTAGEN     111    111       S->A: Abolishes activation of pre-rRNA
FT                                synthesis. {ECO:0000269|PubMed:16618798,
FT                                ECO:0000269|PubMed:22586326}.
FT   MUTAGEN     187    187       H->Y: Abolishes deacetylase activity and
FT                                activation of pre-rRNA synthesis.
FT                                {ECO:0000269|PubMed:16618798,
FT                                ECO:0000269|PubMed:22722849}.
FT   CONFLICT     71     71       L -> Q (in Ref. 2; BAG52860).
FT                                {ECO:0000305}.
FT   CONFLICT    384    384       G -> S (in Ref. 2; BAF82954).
FT                                {ECO:0000305}.
SQ   SEQUENCE   400 AA;  44898 MW;  55D7736A864AFE6F CRC64;
     MAAGGLSRSE RKAAERVRRL REEQQRERLR QVSRILRKAA AERSAEEGRL LAESADLVTE
     LQGRSRRREG LKRRQEEVCD DPEELRGKVR ELASAVRNAK YLVVYTGAGI STAASIPDYR
     GPNGVWTLLQ KGRSVSAADL SEAEPTLTHM SITRLHEQKL VQHVVSQNCD GLHLRSGLPR
     TAISELHGNM YIEVCTSCVP NREYVRVFDV TERTALHRHQ TGRTCHKCGT QLRDTIVHFG
     ERGTLGQPLN WEAATEAASR ADTILCLGSS LKVLKKYPRL WCMTKPPSRR PKLYIVNLQW
     TPKDDWAALK LHGKCDDVMR LLMAELGLEI PAYSRWQDPI FSLATPLRAG EEGSHSRKSL
     CRSREEAPPG DRGAPLSSAP ILGGWFGRGC TKRTKRKKVT
//
